Figure 3.
MH-fusion drove BCP-ALL in combination with NRASG12D mutation. (A) Kaplan-Meier survival analysis of WT, NRASG12D, MH, and MH/NRASG12D mice. The sample size (n) used in this study is indicated. (B) The WBC, hemoglobin (Hgb), and platelet levels of the MH/NRASG12D mice who died were compared with the WT, NRASG12D, and MH mice at the same age. (C) Morphologic analysis with Wright’s staining of the cells in PB, BM, and spleen of WT, NRASG12D, and MH/NRASG12D mice. (D) FACS analysis of cells in the BM. (E) Spleen sizes from WT, NRASG12D, MH, and MH/NRASG12D mice. (F) Hematoxylin and eosin (HE)-stained sections of the spleen derived from WT, NRASG12D, and MH/NRASG12D mice. Data are presented as mean ± standard error of the mean and were analyzed by using the t test. *P < .05, **P < .01.